A Randomized Placebo-Controlled Study of the Efficacy and Safety of Kineret (Anakinra), in Adult Patients With Colchicine-Resistant Familial Mediterranean Fever

Trial Profile

A Randomized Placebo-Controlled Study of the Efficacy and Safety of Kineret (Anakinra), in Adult Patients With Colchicine-Resistant Familial Mediterranean Fever

Completed
Phase of Trial: Phase III

Latest Information Update: 25 Jul 2017

At a glance

  • Drugs Anakinra (Primary)
  • Indications Familial Mediterranean fever
  • Focus Therapeutic Use
  • Most Recent Events

    • 26 Nov 2016 New trial record
    • 11 Nov 2016 Primary endpoint (Number of patients with less than a mean of one FMF attack per month) has been met according to the results published in the Arthritis and Rheumatology.
    • 11 Nov 2016 Results published in the Arthritis and Rheumatology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top